Cargando…
Essentials of the Production of Safe and Efficacious State-of-the-Art Polyclonal IgG Concentrates
Severe noninfectious adverse events (AEs) and transmission of pathogens by plasma-derived protein concentrates from the very beginning of their clinical use were threats for recipients (see Chap. 10.1007/978-3-319-68038-5_11 for additional information). “Standard IgG” preparations were the first ava...
Autor principal: | Späth, Peter J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7122986/ http://dx.doi.org/10.1007/978-3-319-68038-5_12 |
Ejemplares similares
-
Historical Aspects of Polyclonal IgG Preparations
por: Wahn, Volker, et al.
Publicado: (2017) -
A methodological approach for production and purification of polyclonal antibody against dog IgG
por: Sadeghi, Somayeh, et al.
Publicado: (2018) -
Evaluation of Human Anti IgG Polyclonal Antibody Production Conjugated with Peroxidase in Egg Yolk
por: ABDOLMALEKI, Fahimeh, et al.
Publicado: (2019) -
Polyclonal hyperviscosity syndrome in IgG4-related disease and associated conditions
por: Chen, Luke YC, et al.
Publicado: (2015) -
Subclass-restricted IgG polyclonal antibody production in mice injected with lipid A-rich lipopolysaccharides
Publicado: (1981)